Repare Therapeutics

Repare unveils scale of layoffs with 75% of staff and chief medical officer heading for exit
Fierce Biotech
Tue, 02/25/25 - 10:49 am
Repare Therapeutics
layoffs
Repare Therapeutics eyes Phase III cancer study after Mythic trial success
Clinical Trials Arena
Fri, 12/13/24 - 11:48 am
Repare Therapeutics
clinical trials
endometrial cancer
ovarian cancer
Lunre+Camo
Roche dumps Repare's synthetic lethal drug days after making $40M stitch in Tapistry trial
Fierce Biotech
Tue, 02/13/24 - 11:29 am
Roche
Repare Therapeutics
solid tumors
clinical trials
synthetic lethality
Roche deal fails to Repare the licensing scene
EP Vantage
Tue, 06/14/22 - 11:02 am
Roche
Repare Therapeutics
licensing
Roche pays Repare $125M to join Big Pharma peers in cancer race
Fierce Biotech
Thu, 06/2/22 - 10:36 am
Roche
cancer
ovarian cancer
Repare Therapeutics
What pandemic? Biotech floats break records
EP Vantage
Wed, 07/8/20 - 10:37 am
biotech
IPOs
ADC Therapeutics
Akouos
Applied Molecular Transport
Avidity Biosciences
Ayala Pharmaceuticals
Forma Therapeutics
Fusion Pharmaceuticals
Generation Bio
Hyloris Pharmaceuticals
Lantern Pharma
ORIC Pharmaceuticals
Pliant Therapeutics
PolyPid
Repare Therapeutics
Royalty Pharma
SutroVax
The biotech IPOs keep coming at chart-topping levels — with no slowdown in sight
Endpoints
Fri, 06/19/20 - 11:27 am
biotech
IPOs
Repare Therapeutics
Forma Therapeutics
Avidity Biosciences
Vaxcyte
SK Biopharmaceuticals
Generation Bio
Royalty Pharma
After Inking Bristol Myers Pact, Repare Therapeutics Sets Sights on IPO
Xconomy
Sat, 05/30/20 - 08:02 pm
cancer
IPOs
Repare Therapeutics
Bristol-Myers Squibb